Silo Pharma SILO Q4 2023 Results Miss Estimates EPS 036 vs 020 Stephen Mirans Fed Exit How He Set the Stage for Chairmanship Hopeful Kevin Warsh Geopolitical Tensions Rise Political Execution Surge in Iran Raises Market Stability Concerns Udemy UDMY Q1 2026 Disappoints EPS 021 Below 011 Views Roivant Sciences ROIV Slides Support Levels in Focus After 298 Decline Purple Biotech PPBT Edges Higher Modest Uptick Faces Resistance at 304 Sunstone Hotel Investors SHO Edges Lower Navigating a Cautious Hospitality Landscape QuantumScape QS Holds Steady Near Support as Trading Volume Remains Subdued